Mind + Muscle

technical minds + legal muscle


dig deep

Litigation Strategies – Part I – Pharmaceuticals: ANDA Litigation and Generic Drug Approval (Panel Discussion)

  • 09.15.17
  • 10:30 a.m.

This panel will discuss the impact of recent Supreme Court and Federal Circuit decisions on Hatch-Waxman litigation. The panel will discuss the implications of these decisions on both innovator and generic companies.

Panel Moderator: Chandrika Vira, Director

Panelist: Lauren Rabinovic, Ph.D., Vice President and General Counsel, North Americas Generic IP, Teva Pharmaceuticals

Panelist: John Kirkland, Director of IP, Alkermes

Panelist: Dennies Varughese, Pharm.D., Director

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.